Author Guidelines
Permissions
About JCAD
Advertise
Contact
Menu
Author Guidelines
Permissions
About JCAD
Advertise
Contact
Author Guidelines
Permissions
About JCAD
Advertise
Contact
Menu
Author Guidelines
Permissions
About JCAD
Advertise
Contact
Online Exclusives
Supplements
CME Activities
JCAD Archives
Online Exclusives
Supplements
CME Activities
JCAD Archives
Subscribe
Search for:
Search Button
Subscribe
Search for:
Search Button
Online Exclusives
Supplements
CME Activities
JCAD Archives
Online Exclusives
Supplements
CME Activities
JCAD Archives
NP+PA Perspectives in Dermatology: January-February 2024
Prev
Previous
NP+PA Perspectives in Dermatology: December 2023
Next
Use of the 40-gene Expression Profile (40-GEP) Test in Medicare-eligible Patients Diagnosed with Cutaneous Squamous Cell Carcinoma (cSCC) to Guide Adjuvant Radiation Therapy (ART) Decisions Leads to a Significant Reduction in Healthcare Costs
Next
